Tetrakit Technologies ApS

CVR42094943

Core data

Name
Tetrakit Technologies ApS
Address
Ole Maaløes Vej 3, 2200, København N
Founded
Feb 2, 2021
12 / 10
Locations (P-units)
1View locations
Website
https://tetrakit.com/
LinkedIn
tetrakit
Branch
Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)

Keep track of Tetrakit Technologies ApS

Get an email when we detect changes to financial reports, ownership, management or property trades. Save yourself checking the company again.
Free account

Description

TetraKit Technologies is a radiopharmaceutical company founded in 2021 as a spin-out from the University of Copenhagen.

TetraKit develops radiopharmaceuticals in-house and collaborates with partners on their application across oncology. It in-licenses targeting molecules and develops them through its platform, and offers labelling of biomolecules with astatine-211 and other radiohalogens.

Company's own description on virk.dk

The Company's primary activities consist of developing radiopharmaceuticals for the diagnosis and treatment of cancer.

Products & services

In-house radiopharmaceutical development · Tetrakit Platform · Co-development projects · Biomolecule labelling with astatine-211 and other radiohalogens

Industries

Radiopharmaceuticals · Oncology

Customer types

Partners

Analysis by AI ✨

Tetrakit Technologies’ equity rose from DKK -4.1 million in 2024 (restated) to DKK 1 million in 2025, while its 2025 result was a loss of DKK -5.7 million. The 2025 annual report says the 2024 comparative figures were corrected for prior-period errors involving the timing of grants and external expenses.

Ownership changed in 2026: BioInnovation Institute Fonden became a direct owner from 29 June, with 10–14.99% of the capital and 10% of the voting rights. The German legal owner Gnosis Verwaltungsgesellschaft m.b.H. held 10–14.99% of the capital and 10% of the voting rights from 11 November 2025 to 25 June 2026; from 26 June 2026, its holdings were 5–9.99% and 5%. Tetrakit Holdings ApS has been a direct owner since 6 March 2024, with 66.67–89.99% of the capital and 66.67% of the voting rights.

The latest monthly employment record, for August 2026, shows 12 employees and 10 full-time equivalents (FTE). Capital was increased by DKK 6,846 following a decision on 28 October 2025 and registration on 24 November 2025, bringing it to DKK 77,687; on 29 June 2026 it increased by DKK 10,783 to DKK 88,470 through debt conversion.

AI-generated texts are based on registered information, which may be delayed or incomplete. Errors may occur.

Financials

Company financials
Reporting period
2025DKK
Gross profit
-1,516,604
Operating profit
-6,461,832
Profit before tax
-7,115,452
Net income
-5,712,478
Total assets
24,394,710
Equity
1,033,836
Avg. employees
7
2021–2025

Unlock financial history

Datapublica Risk Score

Locked
Assesses the risk of financial distress using the company’s accounts, history, and connections.
Company score
0 · Low100 · High

What goes into the assessment

  • Financials

  • Accounts and history

  • Owners and management

  • Company and connections

Standard: Score and risk bandPro: Also a detailed explanation of the factors

Contact

From cvr.dk

Company
co*****@tetrakit.comShow full

From tetrakit.com

Main
co*****@tetrakit.comShow full

2 consecutive growth years

Børsen Gazelle is Dagbladet Børsen's award. Datapublica is not affiliated with Børsen. Calculated statuses are Datapublica's own analysis of public CVR financial-statement data.

Founders

FounderRegistered as founderCurrent rolesOwnership
Christian Bernard Matthijs PoulieRegistered as founderFeb 2, 2021Current roles
—
Ownership
6.66–13.49 %Indirect via Tetrakit Holdings ApS
Umberto Maria BattistiRegistered as founderFeb 2, 2021Current roles
BoardManagement
Ownership
13.33–22.49 %Indirect via Tetrakit Holdings ApS
Vladimir ShalgunovRegistered as founderFeb 2, 2021Current roles
Board
Ownership
13.33–22.49 %Indirect via Tetrakit Holdings ApS

People

Andreas Tue Ingemann JensenRoles
BoardManagement
TitlesBESTYRELSESMEDLEM • DIREKTØR
Matthias Manfred HerthRoles
BoardManagement
TitlesBESTYRELSESMEDLEM • DIREKTØR
Rune Wiik KristensenRoles
Board
TitlesBESTYRELSESMEDLEM
Umberto Maria BattistiRoles
BoardManagement
TitlesBESTYRELSESMEDLEM • DIREKTØR
Vladimir ShalgunovRoles
Board
TitlesBESTYRELSESMEDLEM

Auditor

Deloitte Statsautoriseret RevisionspartnerselskabAuditorJens SerupRoleState Authorised Public AccountantFromJul 1, 2026
Deloitte Statsautoriseret RevisionspartnerselskabAuditorNicolai Niemann DamtoftRoleState Authorised Public AccountantFromJul 1, 2026
Ownership66.67–89.99 %Voting rights66.67 %FromMar 6, 2024
Ownership10–14.99 %Voting rights10 %FromJun 29, 2026

Unknown Other Participant

Ownership5–9.99 %Voting rights5 %FromJun 26, 2026

Ultimate owners

Andreas Tue Ingemann Jensen
13.33–22.49 %
Matthias Manfred Herth
13.33–22.49 %
Umberto Maria Battisti
Ownership through
13.33–22.49 %
Vladimir Shalgunov
Ownership through
13.33–22.49 %
BioInnovation Institute Fonden
Ownership through
Direct
10–14.99 %
Christian Bernard Matthijs Poulie
Ownership through
6.66–13.49 %
🇩🇪Gnosis Verwaltungsgesellschaft m.b.H.
Ownership through
Direct
5–9.99 %

Official sources